Expression of a splicing variant of the CADM1 specific to small cell lung cancer

Cancer Science

Volumn 103, Issue 6, 2012, Pages 1051-1057

  Kikuchi, Shinji ^a,b   Iwai, Miwako ^a   Sakurai Yageta, Mika ^a   Tsuboi, Yumi ^a   Ito, Takeshi ^a   Maruyama, Tomoko ^a   Tsuda, Hitoshi ^c   Kanai, Yae ^d   Onizuka, Masataka ^b   Sato, Yukio ^b   Murakami, Yoshinori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c National Cancer Research Center Hospital   (Japan)

^d Division of Pathology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CADM1 PROTEIN; CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENICITY; CELL AGGREGATION; CELL MEMBRANE; CONTROLLED STUDY; EXON; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SPHEROID CELL; WESTERN BLOTTING;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; HUMANS; IMMUNOGLOBULINS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; PROTEIN ISOFORMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SMALL CELL LUNG CARCINOMA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 84861677043     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02277.x     Document Type: Article

References (34)

1. Komaki R Combined treatment for limited small cell lung cancer. Semin Oncol 2003; 30: 56-70.
2. Fried P, Wolf K Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-72.
3. D'Angelo SP, Pietanza MC The molecular pathogenesis of small cell lung cancer. Cancer Biol Ther 2010; 10: 1-10.
4. Yokota J, Kohno T Molecular footprints of human lung cancer progression. Cancer Sci 2004; 95: 197-204.
5. Kohno T, Sakiyama T, Kunitoh H et al. Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Carcinogenesis 2006; 27: 2448-54.
6. Kuramochi M, Fukuhara H, Nobukuni T et al. TSLC1 is a tumor suppressor gene in human non-small cell lung cancer. Nat Genet 2001; 27: 427-30.
7. Murakami Y Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene 2002; 21: 6936-48.
8. Masuda M, Yageta M, Fukuhara H et al. The tumor suppressor proteinTSLC1 is involved in cell-cell adhesion. J Biol Chem 2002; 277: 31014-9.
9. Kikuchi S, Yamada D, Fukami T et al. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary non-small cell lung cancer. Cancer 2006; 106: 1751-8.
10. Fukuhara H, Kuramochi M, Fukami T et al. Promoter methylation of theTSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res 2002; 93: 605-9.
11. Allinen M, Peri L, Kujala S et al. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation. Genes Chromosom Cancer 2002; 34: 384-9.
12. Jansen M, Fukushima N, Rosty C et al. Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Cancer Biol Ther 2002; 1: 293-6.
13. Honda T, Tamura G, Waki T et al. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res 2002; 93: 857-60.
14. Ito T, Shimada Y, Hashimoto Y et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 2003; 63: 6320-6.
15. Lung H-L, Cheng Y, Kumaran MK et al. Fine mapping of 11q22-23tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer 2004; 112: 628-35.
16. Steenbergen RD, Kramer D, Braakhuis BJ et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 96: 294-305.
17. Yageta M, Kuramochi M, Masuda M et al. Direct association of TSLC1and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res 2002; 62: 5129-33.
18. Fukuhara H, Masuda M, Yageta M et al. Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of drosophila tumor suppressor Dlg. Oncogene 2003; 22: 6160-5.
19. Shingai T, Ikeda W, Kakunaga S et al. Implications of nectin-likemolecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells. J Biol Chem 2003; 278: 35421-7.
20. Sakurai-Yageta M, Masuda M, Tsuboi Y, Ito A, Murakami Y Tumor suppressor CADM1 is involved in epithelial cell structure. Biochem Biophys Res Commun 2009; 390: 977-82.
21. Gutmann DH, Donahoe J, Perry A et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 2000; 9: 1495-500.
22. Kikuchi S, Yamada D, Fukami T et al. Promoter methylation of the DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Clin Cancer Res 2005; 11: 2954-61.
23. Yamada D, Kikuchi S, Williams YN et al. Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma. Int J Cancer 2006; 118: 916-23.
24. Sasaki H, Nishikata I, Shiraga T et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute type of adult T-cell leukemia. Blood 2005; 105: 1204-13.
25. Dewan MZ, Takamatsu N, Hidaka T et al. Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vitro. J Virol 2008; 82: 11958-63.
26. Masuda M, Maruyama T, Ohta T et al. CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I (HTLV-I) transformed cells and adult T-cell leukemia (ATL) cells. J Biol Chem 2010; 285: 15511-22.
27. Yamada D, Yoshida M, Williams YN et al. Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion molecule. Mol Cell Biol 2006; 26: 3610-24.
28. Takahashi Y, Iwai M, Kawai T et al. Aberrant expression of tumor suppressors, CADM1 and 4.1B, in invasive lesions of primary breast cancer. Breast Cancer 2011; doi: 10.1007/s12282-011-0272-7 [Epub ahead of print].
29. Murakami Y Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci 2005; 96: 543-52.
30. Biederer T Bioinformatic characterization of the SynCAM family of immunoglobulin-like domain-containing adhesion molecules. Genomics 2006; 87: 139-50.
31. Nagano O, Saya H Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95: 930-5.
32. Nagara Y, Hagiyama M, Hatano N et al. Tumor suppressor cell adhesion molecule 1 (CADM1) is cleaved by a disintegrin and metalloprotease 10 (ADAM10) and subsequently cleaved by gamma-secretase complex. Biochem Biophys Res Commun 2012; 17: 462-7.
33. Moore SM, Rintoul RC, Walker TR et al. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Res 1998; 58: 5239-47.
34. Shibata T, Kokubu A, Tsuta K, Hirohashi S Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer. Cancer Lett 2009; 283: 203-11.